专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06583169B2 N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives 失效
标题翻译： N-苯基苯并咪唑酰胺和N-苯基吲哚甲酰胺衍生物
公开(公告)号：US06583169B2
公开(公告)日：2003-06-24
申请号：US09928722
申请日：2001-08-13
申请人： Raymond F. Horvath , Ping Ge , Taeyoung Yoon , Alan Hutchison
发明人： Raymond F. Horvath , Ping Ge , Taeyoung Yoon , Alan Hutchison
IPC分类号： A61K31404
CPC分类号： C07D235/14 , C07D209/14 , G01N2333/726
摘要： Disclosed are compounds of the formula: or the pharmaceutically acceptable non-toxic salts thereof wherein; A is N or CH; R1 and R2 represents hydrogen or lower alkyl; G, R3, R4, R5, R6, R7 and R8 are variables defined herein. These compounds are modulators of CRF receptors and are therefore useful for treating affective disorders, anxiety, depression, eating disorders, and stress disorders in humans and other animals. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided. Compounds of the invention are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.
摘要翻译：公开了下式的化合物或其药学上可接受的无毒盐，其中A是N或CH; R 1和R 2表示氢或低级烷基; G，R 3，R 4，R 5，R 6，R 7和R 8是本文定义的变量这些化合物是CRF受体的调节剂，因此可用于治疗人类和其他动物中的情感障碍，焦虑症，抑郁症，进食障碍和应激障碍。还提供了治疗这种病症以及包装的药物组合物的方法。本发明的化合物还可用作CRF受体定位的探针，并且作为用于CRF受体结合的测定中的标准物。给出了在受体定位研究中使用化合物的方法。

2. 发明授权

US06281237B1 N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives 失效
标题翻译： N-苯基苯并咪唑酰胺和N-苯基吲哚甲酰胺衍生物
公开(公告)号：US06281237B1
公开(公告)日：2001-08-28
申请号：US09540478
申请日：2000-03-31
申请人： Raymond F. Horvath , Ping Ge , Taeyoung Yoon , Alan Hutchison
发明人： Raymond F. Horvath , Ping Ge , Taeyoung Yoon , Alan Hutchison
IPC分类号： A61K314184
CPC分类号： C07D235/14 , C07D209/14 , G01N2333/726
摘要： Disclosed are compounds of the forumla: or the pharmaceutically acceptable non-toxic salts thereof wherein; A is N or CH; R1 and R2 represents hydrogen or lower alkyl; G, R3, R4, R5, R6, R7 and R8 are variables defined herein. These compounds are modulators of CRF receptors and are therefore useful for treating affective disorders, anxiety, depression, eating disorders, and stress disorders in humans and other animals. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided. Compounds of the invention are also useful as probes for the localization of CRF receptors and as standards in assays for CRF receptor binding. Methods of using the compounds in receptor localization studies are given.
摘要翻译：公开了该论坛的化合物或其药学上可接受的无毒盐，其中：A是N或CH; R 1和R 2表示氢或低级烷基; G，R 3，R 4，R 5，R 6，R 7和R 8是本文定义的变量这些化合物是CRF受体的调节剂，因此可用于治疗人类和其他动物中的情感障碍，焦虑症，抑郁症，进食障碍和应激障碍。还提供了治疗这种病症以及包装的药物组合物的方法。本发明的化合物还可用作CRF受体定位的探针，并且作为用于CRF受体结合的测定中的标准物。给出了在受体定位研究中使用化合物的方法。

3. 发明授权

US06670371B2 Certain pyrrolopyridine derivatives: novel CRF1 specific ligands 失效
标题翻译：某些吡咯并吡啶衍生物：新型CRF1特异性配体
公开(公告)号：US06670371B2
公开(公告)日：2003-12-30
申请号：US10096239
申请日：2002-03-12
申请人： Raymond F. Horvath , Alan Hutchison
发明人： Raymond F. Horvath , Alan Hutchison
IPC分类号： A61K31437
CPC分类号： C07D471/04 , C07D471/14
摘要： Disclosed are compounds of the formula: wherein Ar is optionally substituted aryl or heteroaryl R1 is hydrogen or alkyl; R7 is hydrogen or alkyl; R2 is hydrogen, halogen, alkyl or alkoxy; or R1 and R2 taken together with the ring to which they are attached form a 5-9 membered saturated or aromatic ring optionally having a hetero atom selected from oxygen, sulfur or nitrogen; R3 and R4 are independently hydrogen, alkyl, cycloalkyl, aryl or heteroaryl groups; or R3 and R4 together with the nitrogen atom to which they are attached form a 5-8 membered ring; and R5 is hydrogen, halogen, straight or branched chain lower alkyl having 1-6 carbon atoms, or straight or branched chain lower alkoxy or thioalkoxy having 1-6 carbon atoms, which compounds are highly selective partial agonists or antagonists at human Corticotropin-Releasing Factor 1 (CRF1) receptors and are useful in the diagnosis and treatment of treating stress related disorders such as post trumatic stress disorder (PTSD) as well as depression, headache and anxiety.
摘要翻译：公开了下式的化合物：其中Ar是任选取代的芳基或杂芳基R 1是氢或烷基; R 7是氢或烷基; R 2是氢，卤素，烷基或烷氧基; 或者R 1和R 2与它们所连接的环一起形成任选具有选自氧，硫或氮的杂原子的5-9元饱和或芳环; R 3和R 4独立地是氢，烷基，环烷基，芳基或杂芳基团体或R 3和R 4与它们所连接的氮原子一起形成5-8元环; 和R 5是氢，卤素，具有1-6个碳原子的直链或支链低级烷基，或具有1-6个碳原子的直链或支链低级烷氧基或硫代烷氧基，该化合物是人促皮激素释放因子的高选择性部分激动剂或拮抗剂 1（CRF1）受体，可用于诊断和治疗应激相关疾病如后遗传性应激障碍（PTSD）以及抑郁，头痛和焦虑。

4. 发明授权

US6156751A Certain tricyclic substituted diazabicyclo (3.2.1) octane derivatives 失效
标题翻译：某些三环取代的二氮杂双环（3.2.1）辛烷衍生物
公开(公告)号：US6156751A
公开(公告)日：2000-12-05
申请号：US393789
申请日：1999-09-10
申请人： Alan Hutchison , Jun Yuan , Raymond F. Horvath
发明人： Alan Hutchison , Jun Yuan , Raymond F. Horvath
IPC分类号： C07D487/08 , A61K31/495 , C07D247/00
CPC分类号： C07D487/08
摘要： This invention encompasses compounds of the formula: ##STR1## where either R.sub.1 or R.sub.2 represents ##STR2## and the other represents hydrogen or straight or branched chain lower alkyl having 1-6 carbon atoms; andX is oxygen, methylene, or NH;Y is represents various inorganic and organic substituents;Z is hydrogen, amino or NHR.sub.6 where R.sub.6 is lowere alkyl having 1-6 carbon atoms;T is hydrogen, halogen, hydroxy, or lower alkoxy having 1-6 carbon atoms; andA is methylene, carbonyl or CHOH.These compounds are selective partial agonists or antagonists at brain monoamine receptor subtypes or prodrugs thereof and are useful in the diagnosis and treatment of affective disorders such as schizophrenia and depression as well as certain movement disorders such as Parkinsonism. Furthermore compounds of this invention may be useful in treating the extrapyramidal side effects associated with the use of conventional neurolepticagents. These compounds show unexpectedly atypical antipsychotic profiles (clozapine-like) in the animal models described in this patent.
摘要翻译：本发明包括下式的化合物：其中R 1或R 2表示，另一个表示氢或具有1-6个碳原子的直链或支链低级烷基; X为氧，亚甲基或NH; Y代表各种无机和有机取代基; Z是氢，氨基或NHR 6，其中R6是具有1-6个碳原子的低级烷基; T是氢，卤素，羟基或具有1-6个碳原子的低级烷氧基; A是亚甲基，羰基或CHOH。这些化合物是脑单胺受体亚型或其前药的选择性部分激动剂或拮抗剂，并且可用于诊断和治疗情感障碍如精神分裂症和抑郁症以及某些运动障碍如帕金森综合征。此外，本发明的化合物可用于治疗与使用常规精神抑制剂相关的锥体束外副作用。这些化合物在本专利描述的动物模型中显示出意想不到的非典型抗精神病药谱（氯氮平样）。

5. 发明授权

US06355651B1 Certain pyrrolopyridine derivatives; novel CRF1 specific ligands 失效
标题翻译：某些吡咯并吡啶衍生物; 新型CRF1特异性配体
公开(公告)号：US06355651B1
公开(公告)日：2002-03-12
申请号：US09657634
申请日：2000-09-06
申请人： Raymond F. Horvath , Alan Hutchison
发明人： Raymond F. Horvath , Alan Hutchison
IPC分类号： A61K31437
CPC分类号： C07D471/04 , C07D471/14
摘要： Disclosed are compounds of the formula: wherein Ar is optionally substituted aryl or heteroaryl R1 is hydrogen or alkyl; R7 is hydrogen or alkyl; R2 is hydrogen, halogen, alkyl or alkoxy; or R1 and R2 taken together with the ring to which they are attached form a 5-9 membered saturated or aromatic ring optionally having a hetero atom selected from oxygen, sulfur or nitrogen; R3 and R4 are independently hydrogen, alkyl, cycloalkyl, aryl or heteroaryl groups; or R3 and R4 together with the nitrogen atom to which they are attached form a 5-8 membered ring; and R5 is hydrogen, halogen, straight or branched chain lower alkyl having 1-6 carbon atoms, or straight or branched chain lower alkoxy or thioalkoxy having 1-6 carbon atoms, which compounds are highly selective partial agonists or antagonists at human Corticotropin-Releasing Factor 1 (CRF1) receptors and are useful in the diagnosis and treatment of treating stress related disorders such as post trumatic stress disorder (PTSD) as well as depression, headache and anxiety.
摘要翻译：公开了下式的化合物：其中Ar是任选取代的芳基或杂芳基R 1是氢或烷基; R 7是氢或烷基; R 2是氢，卤素，烷基或烷氧基; 或R 1和R 2与它们所连接的环一起形成任选具有选自氧，硫或氮的杂原子的5-9元饱和或芳环; R 3和R 4独立地为氢，烷基，环烷基，芳基或杂芳基团体或R 3和R 4与它们所连接的氮原子一起形成5-8元环; 和R 5是氢，卤素，具有1-6个碳原子的直链或支链低级烷基，或具有1-6个碳原子的直链或支链低级烷氧基或硫代烷氧基，该化合物是人促皮激素释放因子的高选择性部分激动剂或拮抗剂 1（CRF1）受体，可用于诊断和治疗应激相关疾病如后遗传性应激障碍（PTSD）以及抑郁，头痛和焦虑。

6. 发明授权

US6133282A Certain pyrrolopyridine derivatives; novel CRF1 specific ligands 失效
标题翻译：某些吡咯并吡啶衍生物; 新型CRF1特异性配体
公开(公告)号：US6133282A
公开(公告)日：2000-10-17
申请号：US368541
申请日：1999-08-05
申请人： Raymond F. Horvath , Alan Hutchison
发明人： Raymond F. Horvath , Alan Hutchison
IPC分类号： A61P25/24 , C07D471/04 , C07D471/14 , A61K31/437
CPC分类号： C07D471/04 , C07D471/14
摘要： Disclosed are compounds of the formula: ##STR1## wherein Ar is optionally substituted aryl or heteroarylR.sub.1 is hydrogen or alkyl;R.sub.7 is hydrogen or alkyl;R.sub.2 is hydrogen, halogen, alkyl or alkoxy; orR.sub.1 and R.sub.2 taken together with the ring to which they are attached form a 5-9 membered saturated or aromatic ring optionally having a hetero atom selected from oxygen, sulfur or nitrogen;R.sub.3 and R.sub.4 are independently hydrogen, alkyl, cycloalkyl, aryl or heteroaryl groups; orR.sub.3 and R.sub.4 together with the nitrogen atom to which they are attached form a 5-8 membered ring; andR.sub.5 is hydrogen, halogen, straight or branched chain lower alkyl having 1-6 carbon atoms, or straight or branched chain lower alkoxy or thioalkoxy having 1-6 carbon atoms,which compounds are highly selective partial agonists or antagonists at human Corticotropin-Releasing Factor 1 (CRF1) receptors and are useful in the diagnosis and treatment of treating stress related disorders such as post trumatic stress disorder (PTSD) as well as depression, headache and anxiety.
摘要翻译：公开了下式的化合物：其中Ar是任选取代的芳基或杂芳基R 1是氢或烷基; R7是氢或烷基; R2是氢，卤素，烷基或烷氧基; 或者R 1和R 2与它们所连接的环一起形成任选具有选自氧，硫或氮的杂原子的5-9元饱和或芳环; R3和R4独立地是氢，烷基，环烷基，芳基或杂芳基; 或R 3和R 4与它们所连接的氮原子一起形成5-8元环; R5为氢，卤素，具有1-6个碳原子的直链或支链低级烷基，或具有1-6个碳原子的直链或支链低级烷氧基或硫代烷氧基，该化合物是人促皮素激素释放的高度选择性部分激动剂或拮抗剂因子1（CRF1）受体，可用于诊断和治疗应激相关疾病，如创伤后应激障碍（PTSD）以及抑郁，头痛和焦虑。

7. 发明授权

US5955613A Certain pyrrolopyridine derivatives; novel CRF1 specific ligands 失效
标题翻译：某些吡咯并吡啶衍生物; 新型CRF1特异性配体
公开(公告)号：US5955613A
公开(公告)日：1999-09-21
申请号：US542854
申请日：1995-10-13
申请人： Raymond F. Horvath , Alan Hutchison
发明人： Raymond F. Horvath , Alan Hutchison
IPC分类号： C07D471/04 , C07D471/14
CPC分类号： C07D471/04 , C07D471/14
摘要： Disclosed are compounds of the formula: ##STR1## wherein Ar is optionally substituted aryl or heteroarylR.sub.1 is hydrogen or alkyl;R.sub.7 is hydrogen or alkyl;R.sub.2 is hydrogen, halogen, alkyl or alkoxy; orR.sub.1 and R.sub.2 taken together with the ring to which they are attached form a 6 membered aromatic ring optionally having a nitrogen atom,R.sub.3 and R.sub.4 are independently hydrogen, alkyl, cycloalkyl, aryl or heteroaryl groups; or R.sub.3 and R.sub.4 together with the nitrogen atom to which they are attached form a 5-8 membered ring; andR.sub.5 is hydrogen, halogen, straight or branched chain lower alkyl having 1-6 carbon atoms, or straight or branched chain lower alkoxy or thioalkoxy having 1-6 carbon atoms,which compounds are highly selective partial agonists or antagonists at human Corticotropin-Releasing Factor 1 (CRF1) receptors and are useful in the diagnosis and treatment of treating stress related disorders such as post trumatic stress disorder (PTSD) as well as depression, headache and anxiety.
摘要翻译：公开了下式的化合物：其中Ar是任选取代的芳基或杂芳基R 1是氢或烷基; R7是氢或烷基; R2是氢，卤素，烷基或烷氧基; 或者R 1和R 2与它们所连接的环一起形成任选具有氮原子的6元芳环，R 3和R 4独立地是氢，烷基，环烷基，芳基或杂芳基; 或R 3和R 4与它们所连接的氮原子一起形成5-8元环; R5为氢，卤素，具有1-6个碳原子的直链或支链低级烷基，或具有1-6个碳原子的直链或支链低级烷氧基或硫代烷氧基，该化合物是人促皮素激素释放的高度选择性部分激动剂或拮抗剂因子1（CRF1）受体，可用于诊断和治疗应激相关疾病，如创伤后应激障碍（PTSD）以及抑郁，头痛和焦虑。

8. 发明授权

US5952501A Certain tricyclic substituted diazabicylo�3.2.1! octane derivatives 失效
标题翻译：某些三环取代二氮杂双环[3.2.1]辛烷衍生物
公开(公告)号：US5952501A
公开(公告)日：1999-09-14
申请号：US429060
申请日：1995-04-26
申请人： Alan Hutchison , Jun Yuan , Raymond F. Horvath
发明人： Alan Hutchison , Jun Yuan , Raymond F. Horvath
IPC分类号： C07D487/08 , C07D247/00 , A61K31/495
CPC分类号： C07D487/08
摘要： This invention encompasses compounds of the formula: where either R.sub.1 or R.sub.2 represents ##STR1## and the other represents hydrogen or straight or branched chain lower alkyl having 1-6 carbon atoms; andX is oxygen, methylene, or NH;Y is represents various inorganic and organinc substituents;Z is hydrogen, amino or NHR.sub.6 where R.sub.6 is lower alkyl having 1-6 carbon atoms;T is hydrogen, halogen, hydroxy, or lower alkoxy having 1-6 carbon atoms; andA is methylene, carbonyl or CHOH.These compounds are selective partial agonists or antagonists at brain monoamine receptor subtypes or prodrugs thereof and are useful in the diagnosis and treatment of affective disorders such as schizophrenia and depression as well as certain movement disorders such as Parkinsonism. Furthermore compounds of this invention may be useful in treating the extrapyramidal side effects associated with the use of conventional neuroleptic agents. These compounds show unexpectedly atypical antipsychotic profiles (clozapine-like) in the animal models described in this patent.
摘要翻译：本发明包括下式的化合物：其中R 1或R 2表示，另一个表示氢或具有1-6个碳原子的直链或支链低级烷基; X为氧，亚甲基或NH; Y代表各种无机和有机取代基; Z是氢，氨基或NHR6，其中R6是具有1-6个碳原子的低级烷基; T是氢，卤素，羟基或具有1-6个碳原子的低级烷氧基; A是亚甲基，羰基或CHOH。这些化合物是脑单胺受体亚型或其前药的选择性部分激动剂或拮抗剂，并且可用于诊断和治疗情感障碍如精神分裂症和抑郁症以及某些运动障碍如帕金森综合征。此外，本发明的化合物可用于治疗与使用常规精神抑制剂相关的锥体束外副作用。这些化合物在本专利描述的动物模型中显示出意想不到的非典型抗精神病药谱（氯氮平样）。

9. 发明申请

US20070027155A1 Biaryl piperazinyl-pyridine analogues 失效
标题翻译：二芳基哌嗪基 - 吡啶类似物
公开(公告)号：US20070027155A1
公开(公告)日：2007-02-01
申请号：US10893799
申请日：2004-07-16
申请人： Rajagopal Bakthavatchalam , Charles Blum , Harry Brielmann , Bertrand Chenard , Stephane De Lombaert , Kevin Hodgetts , Alan Hutchison , Taeyoung Yoon , Xiaozhang Zheng
发明人： Rajagopal Bakthavatchalam , Charles Blum , Harry Brielmann , Bertrand Chenard , Stephane De Lombaert , Kevin Hodgetts , Alan Hutchison , Taeyoung Yoon , Xiaozhang Zheng
IPC分类号： A61K31/53 , A61K31/506 , C07D43/14
CPC分类号： C04B35/632 , A61K31/496 , A61K31/506 , A61K31/53 , A61K31/5377 , C07D251/48 , C07D401/12 , C07D401/14 , C07D403/14 , C07D413/14
摘要： Biaryl piperazinyl-pyridine analogues are provided, of the Formula: wherein variables are as described herein. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using such compounds to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
摘要翻译：提供了下式的双芳基哌嗪基 - 吡啶类似物：其中变量如本文所述。这些化合物是可用于在体内或体外调节特异性受体活性的配体，并且特别可用于治疗与人类，驯养伴侣动物和家畜中的病理受体激活相关的病症。还提供了使用这些化合物治疗这种病症的药物组合物和方法，以及使用这些配体进行受体定位研究的方法。

10. 发明申请

US20050096358A1 Substituted biaryl amides as C5A receptor modulators 失效
标题翻译：取代的联芳酰胺作为C5A受体调节剂
公开(公告)号：US20050096358A1
公开(公告)日：2005-05-05
申请号：US10994224
申请日：2004-11-19
申请人： Yang Gao , Alan Hutchison , Wallace Pringle , Taeyoung Yoon , He Zhao
发明人： Yang Gao , Alan Hutchison , Wallace Pringle , Taeyoung Yoon , He Zhao
IPC分类号： A61K31/165 , A61K31/341 , A61K31/355 , A61K31/40 , A61K31/401 , A61K31/4025 , A61K31/4164 , A61K31/4178 , C07D207/32 , C07D233/56 , C07D307/40
CPC分类号： C07D209/08 , C07C233/65 , C07C233/66 , C07C233/73 , C07C235/62 , C07C237/30 , C07C2602/08 , C07D207/325 , C07D231/56 , C07D317/58 , C07D333/24 , C07D405/12
摘要： Substituted biaryl amides of Formula I are provided. Such compounds are ligands that may be used to modulate C5a receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological C5a receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
摘要翻译：提供式I的取代的联芳酰胺。这些化合物是可用于在体内或体外调节C5a受体活性的配体，并且特别可用于治疗与人类，驯养的伴侣动物和家畜中的病理性C5a受体激活相关的病症。还提供了用于治疗这些病症的药物组合物和方法，以及使用这些配体进行受体定位研究的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式